Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with the incidence of recurrence being as high as 88% even among patients who …

Hepatocellular carcinoma (HCC) diagnosis and management have undergone significant
improvements in recent years. With the introduction of immunotherapy-based combination …

Simple Summary A large percentage of patients with hepatocellular carcinoma (HCC) who
undergo surgical resection experience a recurrence of their disease. Therefore, predicting …

Background: Although many studies have confirmed the prognostic value of preoperative
alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma (HCC), no one study has …

Abstract Background and Objective According to the Barcelona Clinic Liver Cancer (BCLC)
algorithm, tumor burden and liver function, but not tumor biology, are the key factors in …

Background Alpha-fetoprotein (AFP) expression is closely related to hepatocarcinogenesis,
and it is an important prognostic factor for hepatocellular carcinoma (HCC). We aimed to …

Purpose To develop a prediction model for estimating the expression of vascular endothelial
growth factor receptor 2 (VEGFR2) in hepatocellular carcinoma (HCC) patients using clinical …

Background The impact of viral background on long-term effectiveness of different treatment
modalities for recurrent hepatocellular carcinoma (HCC) was not fully analyzed. Method …

Predicting recurrence patterns of hepatocellular carcinoma (HCC) can be helpful in
developing surveillance strategies. This study aimed to use the hazard function to …

Objective Although radiofrequency ablation (RFA) has been considered as the favorable
treatment option for hepatocellular carcinoma (HCC), there still had some challenges for …